Back to
HSBC Holdings plc
XERS
Showing 6 of 17 quarters
Position history for
HSBC Holdings plc's holdings in Xeris Biopharma Holdings, Inc.
Yes. HSBC Holdings holds 41,779 shares of XERS, worth $329,636, as of its Q2 2026 13F filing. It increased the position by 10,604 shares (+34.0%) from Q1 2026. HSBC Holdings has held XERS since Q1 2026, across 2 quarterly 13F filings.
Current Value
$329,636
Current Shares
41,779
Total Value Change
+$262,320
Total Shares Change
+18,118
Quarter-by-Quarter History